The Biology of Aging: Novel Drug Targets for Neurodegenerative Disease
Symposium - New York City, United States
Age is the greatest risk factor for Alzheimer's disease. Key pathways within the biology of aging may represent important targets to develop novel and effective disease-modifying drugs to treat, delay, or prevent Alzheimer's and other age-related neurodegenerative diseases.
In this 1-day conference, experts will present major recent advances in aging biology that represent important opportunities for drug discovery for Alzheimer's and other age-related neurodegenerative diseases.
The first half of the day will focus on the basic biology of aging-related pathways, with one session on major circuits and a second session on novel targets and pathways.
The second half of the day will focus on drug development programs for neurodegenerative disease based on targets identified from aging biology, including recent scientific advances in the science of autophagy, mitochondrial health, inflammation, and protein homeostasis.
Organization: New York Academy of Sciences
(Courtesy of New York City, United States, via alzdiscovery.org)
The Biology of Aging: Novel Drug Targets for Neurodegenerative Disease
Friday, May 9, 2014 (8:00am - 4:00pm)
New York Academy of Sciences
250 Greenwich Street, 40th Floor, New York City, United States
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
